Theranostic Nanoprobes for Cancer Imaging and Therapy

Theranostic Nanoprobes for Cancer Imaging and Therapy

Molecular imaging technologies have undergone massive expansion during the previous decade and are now posed to play crucial role in clinical oncology. In that context, development of imaging nanoprobes is necessary for providing information on molecular signals and biomarkers of malignancies in real time, which could aid in cancer detection and in following tumor response to chemotherapy. Nanotechnology could potentially offer highly sensitive imaging agents capable of detecting primary tumors as well as micrometastasis. Recent developments in theranostic nanoprobes for cancer imaging and therapy offer great potential in cancer management. This presentation will focus on applications of nanotechnology in cancer imaging and will address the potential of various platforms for cancer detection, staging and image-guided therapy.